View a ticker or compare two or three
NXTC
Daily Signal changed days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

NXTC is expected to report earnings to fall 38.25% to -37 cents per share on August 01

NextCure NXTC Stock Earnings Reports
Q2'24
Est.
$-0.38
Q1'24
Missed
by $0.17
Q4'23
Est.
$-0.52
Q3'23
Beat
by $0.15
Q2'23
Missed
by $0.09
The last earnings report on May 02 showed earnings per share of -61 cents, missing the estimate of -43 cents. With 48.83K shares outstanding, the current market capitalization sits at 47.27M.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company which discovers and develops novel immuno medicines to treat cancer & immune related diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
9000 Virginia Manor Road
Phone
+1 240 399-4900
Employees
82
Web
https://www.nextcure.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UHG6.420.22
+3.55%
United Homes Group
EUDA4.000.07
+1.78%
EUDA Health Holdings Limited
MNST50.89-0.12
-0.24%
Monster Beverage Corp
HR17.46-0.06
-0.34%
Healthcare Realty Trust
VIR10.03-0.19
-1.86%
Vir Biotechnology

NXTC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NXTC has been loosely correlated with CYTK. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if NXTC jumps, then CYTK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NXTC
1D Price
Change %
NXTC100%
+0.60%
CYTK - NXTC
37%
Loosely correlated
+0.89%
FATE - NXTC
35%
Loosely correlated
-0.93%
ORMP - NXTC
33%
Poorly correlated
+1.19%
RPHM - NXTC
32%
Poorly correlated
+0.68%
GOSS - NXTC
32%
Poorly correlated
-1.90%
More